CETUXIMAB VERSUS BEVACIZUMAB IN METASTATIC COLORECTAL CANCER: A COMPARATIVE EFFECTIVENESS AND PATIENT-REPORTED OUTCOMES MULTICOHORT STUDY

被引：0
|
作者：
Marques, R. P. [1 ]
Heudtlass, P. [2 ]
Godinho, A. R. [2 ]
Pais, H. L. [1 ]
Quintela, A. [1 ]
Lopes, da Cruz J. P. [1 ]
Martins, A. P. [3 ]
机构：
[1] Ctr Hosp Univ Lisboa Norte, Lisbon, Portugal
[2] Ctr Hlth Evaluat & Res, Lisbon, Portugal
[3] Univ Lisbon, Fac Pharm, Lisbon, Portugal
来源：
VALUE IN HEALTH | 2021年 / 24卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN18
引用
收藏
页码：S21 / S21
页数：1
相关论文
共 50 条
  • [21] Patient-reported care coordination and outcomes of colorectal cancer surgery
    Hawley, Sarah T.
    Regenbogen, Scott E.
    Veenstra, Christine Marie
    Morris, Arden M.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [22] Effectiveness and Cost Effectiveness of Bevacizumab in Metastatic Colorectal Cancer
    Messori, Andrea
    De Rosa, Mauro
    Fadda, Valeria
    Pani, Luca
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (32) : 3838 - +
  • [23] Cetuximab after bevacizumab in metastatic colorectal cancer: Is it the best sequence?
    Norguet, Emmanuelle
    Dahan, Laetitia
    Gaudart, Jean
    Gasmi, Mohamed
    Ouafik, L'houcine
    Seitz, Jean-Francois
    DIGESTIVE AND LIVER DISEASE, 2011, 43 (11) : 917 - 919
  • [24] COST ANALYSIS OF METASTATIC COLORECTAL CANCER TREATMENT WITH BEVACIZUMAB AND CETUXIMAB
    Maria Vieitez, Jose
    Oyaguez, Itziar
    Angel Casado, Miguel
    ANNALS OF ONCOLOGY, 2011, 22 : v84 - v84
  • [25] Appraisal of bevacizumab and cetuximab for treatment of metastatic colorectal cancer in the UK
    Barnett, David
    Stevens, Andrew
    Longson, Carole
    LANCET ONCOLOGY, 2006, 7 (10): : 807 - 808
  • [26] Comparative effectiveness and safety of monoclonal antibodies (bevacizumab, cetuximab and panitumumab) in the treatment of metastatic colorectal cancer: Systematic review and metanalysis.
    Silva, Wania Cristina
    Lima, Ellias Magalhaes Abreu
    Araujo, Vania Eloisa
    Santos, Jessica Barreto Ribeiro
    Silva, Michael Ruberson Ribeiro
    Acurcio, Francisco Assis
    Cherchiglia, Mariangela Leal
    Andrade, Eli Iola Gurgel
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [27] Patient-reported outcomes in long-term survivors of metastatic colorectal cancer needing liver resection
    Rees, J. R.
    Blazeby, J. M.
    Brookes, S. T.
    John, T.
    Welsh, F. K.
    Rees, M.
    BRITISH JOURNAL OF SURGERY, 2014, 101 (11) : 1468 - 1474
  • [28] Cost-Effectiveness Analysis of Bevacizumab Biosimilars Versus Originator Bevacizumab for Metastatic Colorectal Cancer: A Comparative Study Using Real-World Data
    Lu, Brandon
    Dvorani, Erind
    Nguyen, Lena
    Beca, Jaclyn M.
    Mercer, Rebecca E.
    Adamic, Andrea
    Munoz, Caroline
    Chan, Kelvin K. W.
    VALUE IN HEALTH, 2024, 27 (12) : 1689 - 1697
  • [29] A Phase II Study of Capecitabine, Oxaliplatin, Bevacizumab and Cetuximab in the Treatment of Metastatic Colorectal Cancer
    Wong, Nan Soon
    Fernando, Nishan H.
    Nixon, Andrew B.
    Cushman, Stephanie
    Aklilu, Mebea
    Bendell, Johanna C.
    Morse, Michael A.
    Blobe, Gerard C.
    Ashton, Jill
    Pang, Herbert
    Hurwitz, Herbert I.
    ANTICANCER RESEARCH, 2011, 31 (01) : 255 - 261
  • [30] Patient-reported outcomes in metastatic castration-resistant prostate cancer
    Fallowfield, Lesley
    Payne, Heather
    Jenkins, Valerie
    NATURE REVIEWS CLINICAL ONCOLOGY, 2016, 13 (10) : 643 - 650
12345